91ºÚÁÏÍø

In-person class cancellation and work-from-home / Annulation des cours en présentiel et télétravail

Updated: Tue, 03/10/2026 - 17:14
In-person class cancellation and work-from-home / Annulation des cours en présentiel et télétravail. McGILL ALERT! Due to freezing rain all in-person classes and activities on Wednesday, March 11, will be cancelled. Staff are asked not to come to campus tomorrow unless they are required on site by their supervisor to perform necessary functions and activities. See your 91ºÚÁÏÍø email for more information.
...
ALERTE McGILL! En raison de la pluie verglaçante, tous les cours et activités en présentiel prévus pour le mercredi 11 mars sont annulés. Nous demandons au personnel de ne pas se présenter sur le campus demain, à moins que leur superviseur ne leur demande d’être sur place pour accomplir des fonctions ou activités nécessaires au fonctionnement du campus. Pour plus d’informations, veuillez consulter vos courriels de 91ºÚÁÏÍø.

Anna Blakney

Academic title(s): 

Assistant Professor

Anna Blakney
Branch: 
University of British Columbia
Department: 
Laboratoires Micheal Smith et école d'ingénierie biomédicale
Areas of expertise: 
  • Self-amplifying RNA
  • lipid nanoparticles
  • gene therapy
  • drug delivery
  • immunoengineering
Biography: 

Dr. Anna Blakney is an Assistant Professor and Tier 2 Canada Research Chair in the Michael Smith Laboratories and School of Biomedical Engineering at UBC. She received her Bachelor of Science in Chemical & Biological Engineering from the University of Colorado at Boulder, and her PhD in Bioengineering from the University of Washington. She completed a postdoctoral fellowship at Imperial College London on the development of molecular and biomaterial engineering strategies for delivery of self-amplifying RNA. Her lab uses bioengineering, molecular biology and immunology approaches to develop the next generation of RNA vaccines and therapies. Her research has been published in a variety of top tier journals including ACS Nano, Nature Communications, Molecular Therapy, Biomaterials, Journal of Controlled Release, and Advanced Materials. Dr. Blakney has received numerous awards including the 2023 MIT Tech Review’s 35 Innovators Under 35, 2022 Gairdner Early Career Investigator Award, the 2021 UBC President’s Award for Public Education Through Media and the 2022 Controlled Release Society Gene Delivery and Editing Focus Group Young Investigator Award.

Back to top